十一月 2025
- Home
- ChemDiv
十一月 2025的ChemDiv市场份额分析
chemdiv inc - fully integrated target-to-clinic contract research organization (cro)
ChemDiv(包含公司地区分支机构)
查看更多网站流量和参与度信息- chemdiv.com
ChemDiv收入截至 十一月 2025为 200M - 500M
ChemDiv主要域名产生的收入
3 年中ChemDiv主要域名的收入
ChemDiv主要域名的收入
ChemDiv热门域名的总访问量
了解ChemDiv市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
ChemDiv热门域名的平均访问时长
分析ChemDiv参与度指标。
过去 3 个月的平均访问时长
子公司明细
ChemDiv热门域名的平均页面浏览量
了解ChemDiv如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
ChemDiv 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻ChemDiv, Inc. launched Chemistry, Manufacturing and Controls on Oct 30th '25.SAN DIEGO, Oct. 30, 2025 /PRNewswire/ - ChemDiv, a global provider of integrated drug discovery solutions, today announced the extension of its Chemistry, Manufacturing and Controls (CMC) services collaboration supporting the clinical development of ratutrelvir, a promising oral antiviral treatment for COVID-19.
十月 30, 2025阅读更多
新闻ChemDiv, Inc. partnered with Mondego Bio on Oct 24th '25.SAN DIEGO, Oct. 24, 2025 /PRNewswire/ - ChemDiv today announced the extension of its discovery and early development partnership with Mondego Bio to advance the company's best-in-class immuno-oncology program targeting PTPN2.
十月 27, 2025阅读更多
新闻ChemDiv, Inc. partnered with University of Texas Medical Branch on Dec 28th '23.SAN DIEGO, Dec. 28, 2023 /PRNewswire/ - ChemDiv, a global leader in drug discovery solutions, announces a strategic collaboration with the University of Texas Medical Branch (UTMB) to facilitate the expansion of its inventory and advance the institution's High-throughput Screening (HTS) research programs.
十二月 27, 2023阅读更多
查看 ChemDiv 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。